The North America infectious disease diagnostics market size was valued at USD 8.98 billion in 2025 and is expected to reach USD 15.39 billion by 2033, at a CAGR of 6.90% during the forecast period
The market growth is largely fueled by the increasing prevalence of infectious diseases, rising demand for rapid and accurate diagnostic solutions, and continuous technological advancements in molecular diagnostics and point-of-care testing, leading to improved disease detection and surveillance across hospitals, diagnostic laboratories, and community healthcare settings
Furthermore, growing government initiatives for disease control and prevention, expanding healthcare infrastructure, increased funding for public health programs, and rising awareness regarding early diagnosis are accelerating the adoption of infectious disease diagnostic solutions, thereby significantly boosting the industry's growth